Why EXACT Sciences Corporation Is Rising Today

Shares of EXACT Sciences (NASDAQ: EXAS), a company focused on colon-cancer detection, rose as much as 13% in early morning trading on Wednesday in response to reporting better-than-expected second-quarter results.

Here's a review of the key highlights from the period that have traders feeling giddy today:

The solid quarterly performance allowed management to significantly raise its guidance for the year. Management now expects to complete at least 550,000 Cologuard tests during 2017. That's quite a big jump from the 470,000 tests that management had forecasted just three months ago.

Source: Fool.com